These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 6411952
21. [Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy]. Inoi T, Mojamdar M, Ichihashi M, Mishima Y. Nihon Hifuka Gakkai Zasshi; 1982 Sep; 92(10):1065-9. PubMed ID: 6821170 [No Abstract] [Full Text] [Related]
22. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese. Ito S, Kato T, Fujita K. Acta Derm Venereol; 1987 Sep; 67(2):163-5. PubMed ID: 2438883 [Abstract] [Full Text] [Related]
23. [Melanoma metabolites (proceedings)]. Rorsman H. Lakartidningen; 1978 Dec 06; 75(49):4596-7. PubMed ID: 723347 [No Abstract] [Full Text] [Related]
24. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma. Kärnell R, von Schoultz E, Hansson LO, Nilsson B, Arstrand K, Kågedal B. Melanoma Res; 1997 Oct 06; 7(5):393-9. PubMed ID: 9429222 [Abstract] [Full Text] [Related]
25. [High-performance liquid chromatographic determination of urinary 5-S, 2-S-, 6-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa (author's transl)]. Morishima T, Saito M, Fujita M, Fukada E, Hanawa S. Nihon Hifuka Gakkai Zasshi; 1982 Jan 15; 92(1):53-6. PubMed ID: 6804671 [No Abstract] [Full Text] [Related]
28. Studies on amelanotic melanoma with the fluorescence method (Falck and Hillarp) and biochemical analysis of 5-S-cysteinyldopa in the tissues. Morishima T, Tatsumi F, Fukada E, Watanabe M, Nagashima N, Hanawa S. Arch Dermatol Res; 1983 Jan 15; 275(5):329-33. PubMed ID: 6419680 [Abstract] [Full Text] [Related]
29. Determination of urinary 5-S-cysteinyldopa by high-performance liquid chromatography. Kågedal B, Pettersson A. J Chromatogr; 1983 Feb 11; 272(2):287-97. PubMed ID: 6403561 [Abstract] [Full Text] [Related]
32. [Urinary evaluation of 5-S-cysteinyldopa and seric evaluation of IgG4 subclass during follow-up of 27 primitive malignant melanomas (author's transl)]. Cesarini JP, Daveau M, Picard F, Fournier E, Rivat L, Rivat C. Ann Dermatol Venereol; 1978 Apr 11; 105(4):405-8. PubMed ID: 686614 [Abstract] [Full Text] [Related]
33. [Diagnosis of amelanotic malignant melanoma by means of the fluorescence method (Falck & Hillarp) and determination of 5-S-cysteinyldopa in the lesions]. Morishima T, Fukada E, Nagashima N. Nihon Hifuka Gakkai Zasshi; 1983 Jan 11; 93(1):51-4. PubMed ID: 6408288 [No Abstract] [Full Text] [Related]
35. Excretion of 5-s-cysteinyldopa in humans with genetically dark skin. Agrup G, Hansson C, Juldorf F, Rorsman H, Rosengren AM, Rosengren E. Acta Derm Venereol; 1979 Jan 11; 59(1):69-70. PubMed ID: 84471 [Abstract] [Full Text] [Related]
36. The value of cysteinyldopa in the follow-up of disseminated malignant melanoma. Kärnell R, Kågedal B, Lindholm C, Nilsson B, Arstrand K, Ringborg U. Melanoma Res; 2000 Aug 11; 10(4):363-9. PubMed ID: 10985671 [Abstract] [Full Text] [Related]